Publications by authors named "Kevin Foy"

Claim this Profile
G
Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington's Disease Using the Enroll-HD Global Platform.
Alexander L Symonds, Antonella Macerollo, Kevin Foy, Sundus H Alusi, Rhys Davies

Int J Environ Res Public Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of the unique challenges facing African-American breast cancer survivors.
Marium Husain, Timiya S Nolan, Kevin Foy, Raquel Reinbolt, Cassandra Grenade

Support Care Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women.
Kevin Chu Foy, James L Fisher, Maryam B Lustberg, Darrell M Gray, Cecilia R DeGraffinreid

NPJ Breast Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1.
Eduardo Sanabria-Figueroa, Siobhan M Donnelly, Kevin C Foy, Meghan C Buss, Robert C Castellino

Mol Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.
Kevin Chu Foy, Megan J Miller, Jay Overholser, Siobhan M Donnelly, Rita Nahta

Oncoimmunology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells.
Megan Jo Miller, Kevin C Foy, Jay P Overholser, Rita Nahta, Pravin Tp Kaumaya

Oncoimmunology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo.
Kevin Chu Foy, Ruthie M Wygle, Megan J Miller, Jay P Overholser, Tanios Bekaii-Saab

J Immunol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.
Megan Jo Miller, Kevin Chu Foy, Pravin T P Kaumaya

Discov Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060.
Kevin C Foy, Megan J Miller, Nicanor Moldovan, William E Carson, Pravin P T Kaumaya

Oncoimmunology· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer.
Kevin C Foy, Megan J Miller, Nicanor Moldovan, Tatjana Bozanovic, William E Carson

Oncoimmunology· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo.
Kevin C Foy, Megan J Miller, Nicanor Moldovan, William E Carson, Pravin T P Kaumaya

Oncoimmunology· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.
Pravin T P Kaumaya, Kevin Chu Foy

Future Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leprechauns and Lewy body disease.
Kevin Foy

Transcult Psychiatry· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.
Daniele Vicari, Kevin C Foy, Eric M Liotta, Pravin T P Kaumaya

J Biol Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo.
Kevin C Foy, Zhenzhen Liu, Gary Phillips, Megan Miller, Pravin T P Kaumaya

J Biol Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not a laughing matter.
Kevin Foy, Kieran C Murphy, Joan T Moroney

J Neuropsychiatry Clin Neurosci· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I active immunotherapy with combination of two chimeric, human epidermal growth factor receptor 2, B-cell epitopes fused to a promiscuous T-cell epitope in patients with metastatic and/or recurrent solid tumors.
Pravin T P Kaumaya, Kevin Chu Foy, Joan Garrett, Sharad V Rawale, Daniele Vicari

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-concussion syndrome.
Kevin Foy, Kieran C Murphy

Br J Hosp Med (Lond)· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term social functioning after depression treated by psychiatrists: a review.
Noel Kennedy, Kevin Foy, Rafay Sherazi, Michael McDonough, Patrick McKeon

Bipolar Disord· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of residual symptoms on outcome of major depression.
Noel Kennedy, Kevin Foy

Curr Psychiatry Rep· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis